Effectiveness of daily and weekly iron supplementatio

Phase 4

• Conditions: Anemia in infant; Anemia in Infant

• Registration Number: TCTR20150824001
• Lead Sponsor: ๊Queen Savang Vadhana Memorial Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-08-24
• Study Completion: 2016-03-10
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 128

Inclusion Criteria

1) age 5-7 months
2) can swallow ferrous fumarate oral suspension
3) parents are willing to follow the studied protocal
4) can be followed up at 1 year old or 6 month

Exclusion Criteria

1) presents thalassemia
2) has history of cardiology, respiratory, gastrointestinal diseases, or other diseases that can be obstacle to the study
3) has history of sensitivity or reaction to ferrous fumarate
4) on medication that reacts to ferrous fumarate

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prevalence of anemia 6 months after receiving ferrous fumarate Hemocue Hb 201+

Secondary Outcome Measures

Name	Time	Method
Drug adherence 6 months after receiving ferrous fumarate questionnaire